Derma Sciences, Inc. Reports Second Quarter 2012 Financial Results

August 14, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2012.

Twitter
LinkedIn
Facebook
Email
Print

Earnings